Ken Griffin’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-250,719
| Closed | -$54.4M | – | 14961 |
|
|
2021
Q1 | $54.4M | Buy |
250,719
+220,913
| +741% | +$41.5M | 0.01% | 991 |
|
|
2020
Q4 | $3.44M | Sell |
29,806
-72,591
| -71% | -$8.13M | ﹤0.01% | 4350 |
|
|
2020
Q3 | $9.97M | Sell |
102,397
-741,353
| -88% | -$85.3M | ﹤0.01% | 2303 |
|
|
2020
Q2 | $104M | Sell |
843,750
-133,236
| -14% | -$15.1M | 0.04% | 388 |
|
|
2020
Q1 | $85.6M | Buy |
976,986
+699,524
| +252% | +$74.1M | 0.04% | 399 |
|
|
2019
Q4 | $29M | Sell |
277,462
-723,444
| -72% | -$81.1M | 0.01% | 1154 |
|
|
2019
Q3 | $115M | Buy |
1,000,906
+554,472
| +124% | +$84.2M | 0.05% | 346 |
|
|
2019
Q2 | $77M | Sell |
446,434
-90,819
| -17% | -$15.7M | 0.04% | 507 |
|
|
2019
Q1 | $90.6M | Buy |
537,253
+46,496
| +9% | +$6.92M | 0.05% | 403 |
|
|
2018
Q4 | $47.8M | Sell |
490,757
-434,644
| -47% | -$57M | 0.03% | 649 |
|
|
2018
Q3 | $160M | Buy |
925,401
+494,640
| +115% | +$71.3M | 0.07% | 247 |
|
|
2018
Q2 | $60.1M | Sell |
430,761
-424,449
| -50% | -$60.3M | 0.03% | 600 |
|
|
2018
Q1 | $96.4M | Buy |
855,210
+141,100
| +20% | +$17.7M | 0.05% | 336 |
|
|
2017
Q4 | $94.3M | Buy |
714,110
+549,911
| +335% | +$64.6M | 0.06% | 353 |
|
|
2017
Q3 | $16.7M | Buy |
164,199
+119,904
| +271% | +$12.8M | 0.01% | 1204 |
|
|
2017
Q2 | $4.44M | Sell |
44,295
-836
| -2% | -$90K | ﹤0.01% | 2245 |
|
|
2017
Q1 | $5.46M | Sell |
45,131
-36,443
| -45% | -$4.47M | 0.01% | 1949 |
|
|
2016
Q4 | $9.12M | Buy |
81,574
+78,710
| +2,748% | +$9.47M | 0.01% | 1440 |
|
|
2016
Q3 | $380K | Sell |
2,864
-62,862
| -96% | -$6.01M | ﹤0.01% | 5285 |
|
|
2016
Q2 | $6.02M | Buy |
65,726
+40,504
| +161% | +$3.41M | 0.01% | 1666 |
|
|
2016
Q1 | $1.82M | Sell |
25,222
-26,041
| -51% | -$1.43M | ﹤0.01% | 2747 |
|
|
2015
Q4 | $3.56M | Buy |
51,263
+22,894
| +81% | +$1.86M | ﹤0.01% | 2144 |
|
|
2015
Q3 | $2.59M | Buy |
28,369
+21,270
| +300% | +$2.37M | ﹤0.01% | 2626 |
|
|
2015
Q2 | $872K | Buy |
7,099
+1,791
| +34% | +$203K | ﹤0.01% | 4153 |
|
|
2015
Q1 | $484K | Sell |
5,308
-7,345
| -58% | -$596K | ﹤0.01% | 4955 |
|
|
2014
Q4 | $856K | Sell |
12,653
-13,361
| -51% | -$976K | ﹤0.01% | 3952 |
|
|
2014
Q3 | $2.1M | Sell |
26,014
-59,676
| -70% | -$5.28M | ﹤0.01% | 2800 |
|
|
2014
Q2 | $9.19M | Buy |
85,690
+32,503
| +61% | +$2.26M | 0.01% | 1327 |
|
|
2014
Q1 | $3.16M | Buy |
+53,187
| New | +$3.16M | ﹤0.01% | 2187 |
|
Other funds holding GWPH
Ken Griffin's GWPH Position: Q2 2021 in Review
Ken Griffin sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 250,719 shares — an estimated $54.4M sold.
Ken Griffin first reported a position in GWPH in Q1 2014 and held it in 29 quarters. The position peaked at $160M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Ken Griffin reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Ken Griffin sold 250,719 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $54.4M.
- Ken Griffin first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 29 quarters.
- Ken Griffin's GW Pharmaceuticals Plc American Depositary Shares position peaked at $160M in Q3 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.